AHA Regarding the 340B Program

AHA to the Subcommittee on Oversight and Investigations Committee on Energy and Commerce regarding the 340B program.

Key Resources

Related Resources

Letter/Comment
AHA Submits Comments on CMS Guidance For Medicare Drug Price Negotiation Program
Public
Letter/Comment
AHA Letter to Reps. Fischbach and Pence Expressing Support of Congressional Review Act (CRA) Resolutions
Public
Letter/Comment
AHA Letter to House Energy and Commerce Committees on Value of 340B Program
Public
Action Alert
Contact your Representative Prior to June 4 House Subcommittee Hearing on 340B
Member Non-Fed
Infographics
Drug Prices and Shortages Increase Hospitals’ Costs and Jeopardize Patient Access to Care Infographic
AHA Center for Health Innovation Market Scan
3 Ways GLP-1 Drugs Could Impact Your Hospital’s Future